Email Alert | RSS

Most Down Articles

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    Most Downloaded in Recent Year
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Journal of Tuberculosis and Lung Health    2013, 35 (4): 290-292.  
    Abstract1035)      PDF(pc) (545KB)(71348)       Save
    Related Articles | Metrics
    Application of weighted TOPSIS with RSR on comprehensive evaluation of tuberculosis control quality
    DENG Bin,PENG Jian-mei,LUO Lan- Jiao,WANG Lei
    Journal of Tuberculosis and Lung Health    2015, 37 (9): 960-965.   DOI: 10.3969/j.issn.1000-6621.2015.05.009
    Abstract861)      PDF(pc) (889KB)(5036)       Save
    Related Articles | Metrics
    Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in smear-negative pulmonary tuberculosis
    Yan Xiaojing, Wang Qingfeng, Yang Yang, Chu Naihui, Nie Wenjuan
    Chinese Journal of Antituberculosis    2023, 45 (5): 487-492.   DOI: 10.19982/j.issn.1000-6621.20230036
    Abstract375)   HTML30)    PDF(pc) (758KB)(4595)       Save

    Objective: To determine the diagnostic accuracy of a nanopore sequencing assay for testing of bronchoalveolar lavage fluid (BALF) samples from suspected pulmonary tuberculosis (PTB) patients. Methods: Fifty cases with suspected PTB from Beijing Chest Hospital from November 2021 to April 2022 were collected. These cases were diagnosed based on results of MGIT 960 culture, GeneXpert MTB/RIF testing and nanopore sequencing of BALF samples collected during hospitalization. Taking the final clinical diagnosis as the reference standard, diagnostic accuracies of the three assays were compared. Results: Among the 50 cases analysed in this study, 22 (44.0%) were diagnosed as tuberculosis, 10 (20.0%) non-tuberculous mycobacteria and 18 (36.0%) bacterial pneumonia. Taking the clinic diagnosis as the reference standard, the sensitivity of nanopore sequencing assay technology, MGIT 960 culture and Xpert assay were 72.7% (16/22), 27.3% (6/22) and 31.8% (7/22), respectively, the specificity were 78.6% (22/28), 75.0% (21/28) and 96.4% (27/28), respectively, the accuracy were 76.0% (38/50), 54.0% (27/50) and 68.0% (34/50), respectively, and the Yoden index was 0.51, 0.02 and 0.28, respectively. Conclusion: Nanopore sequencing assay of BALF samples may have better diagnostic performance than Xpert and MGIT 960 cultures, and may improve the positive detection rate of BALF in suspected PTB patients. But this method cannot exclude pulmonary tuberculosis.

    Table and Figures | Reference | Related Articles | Metrics
    Progress in diagnosis and treatment of latent tuberculosis infection
    LI Guo, PANG Xian-qiong, XU Hua, JING Ming-yan, FAN Pang-shuang, CHEN Shao-ping
    Chinese Journal of Antituberculosis    2021, 43 (1): 91-95.   DOI: 10.3969/j.issn.1000-6621.2021.01.017
    Abstract880)   HTML54)    PDF(pc) (879KB)(2483)       Save

    Latent tuberculosis infection (LTBI) is a status of persistent immune response to stimulation by Mycobacterium tuberculosis antigens. Because of the risk of developing active tuberculosis, LTBI has been paid more and more attentions worldwide. The screening and preventive treatment of LTBI is an important component in the comprehensive prevention and control program of tuberculosis. However, there is no direct diagnosis method and unified treatment regimen for LTBI. In addition to the two conventional methods using for LTBI screening, tuberculin skin test and interferon gamma release assays, a newly developed method of recombinant Mycobacterium tuberculosis fusion protein (EC) (The generic name in Chinese of this product determined by the Chinese Pharmacopoeia Committee is used. “EC” is the recombinant fusion protein of “early secretory antigenic target-6 (ESAT-6) and culture filtrate protein 10 (CFP-10)”) can also be used in China. Currently, the preventive treatment with single-drug isoniazid is the most widely used regimen, but the regimen with rifamycin has more obvious advantages due to the shorter treatment duration and higher treatment compliance. So far, there are relatively few studies in the field of LTBI in China, and the coverage rate of preventive treatment for LTBI is low. Researchers related to LTBI should be conducted actively to explore the preventive treatment regimen in line with national conditions.

    Reference | Related Articles | Metrics
    Chinese Journal of Antituberculosis    2023, 45 (7): 714-717.   DOI: 10.19982/j.issn.1000-6621.20230144
    Abstract303)   HTML22)    PDF(pc) (1576KB)(1590)       Save
    Table and Figures | Reference | Related Articles | Metrics
    Interpretation of WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection
    Xin Henan, Gao Lei
    Chinese Journal of Antituberculosis    2023, 45 (7): 639-643.   DOI: 10.19982/j.issn.1000-6621.20230128
    Abstract642)   HTML83)    PDF(pc) (954KB)(766)       Save

    On September 30, 2022, the World Health Organization (WHO) published the WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection. The medical evidence-based guideline systematically evaluated the performance of different tests and recommended using of Mycobacterium tuberculosis antigen-based skin tests for the diagnosis of tuberculosis infection for the first time. The author now introduces the development of the new guideline and interprets the three key recommendations hoping to provide evidence-based reference for tuberculosis infection test and control.

    Reference | Related Articles | Metrics
    A prospective study on occurrence of venous thromboembolism after spinal tuberculosis surgery
    Jian-dong CHEN,Chen ZHANG,Rui-rui MIAO,Wen-long ZHANG
    Journal of Tuberculosis and Lung Health    2018, 40 (5): 490-493.   DOI: 10.3969/j.issn.1000-6621.2018.05.010
    Abstract565)   HTML4)    PDF(pc) (728KB)(1419)       Save

    Objective To investigate the incidence of deep venous thromboembolism (DVT) after the operation of the patients with spinal tuberculosis, and to explore the necessity of adopting relevant measures to prevent occurrence of DVT during perioperative period.Methods This study was conducted in 146 patients with spinal tuberculosis who underwent surgery from the same group of physicians and did not receive anticoagulation from May 2012 to August 2017 in Haihe Hospital. Preoperative blood routine examination, coagulation index and double lower limb venous color Doppler ultrasonography were performed; after the operation, the double lower extremity venous color Doppler ultrasound were repeated, and follow-up for 3 months.Results Among the 146 patients who were confirmed to have no DVT before operation, the DVT was found in 11 cases and no pulmonary embolism (PE) cases were diagnosed. The spontaneous incidence of DVT after spinal tuberculosis surgery was 7.53%. All patients with postoperative DVT after 7-10 days of operation had the calf muscle venous thrombosis which located in the far beyond the knee. The patients had no obvious clinical symptoms and did not receive related treatment. The DVT disappeared after 3 months of review of doppler ultrasound.Conclusion In the perioperative period of spinal tuberculosis operation, DVT have a higher natural incidence without anticoagulation. All patients with DVT do not have serious consequences, and the perioperative period of spinal tuberculosis do not need conventional drugs to prevent DVT.

    Reference | Related Articles | Metrics
    Journal of Tuberculosis and Lung Health    2017, 39 (5): 542-544.   DOI: 10.3969/j.issn.1000-6621.2017.05.026
    Abstract453)      PDF(pc) (1167KB)(2687)       Save
    Related Articles | Metrics
    The fifth national tuberculosis epidemiological survey in 2010
    Technical Guidance Group of the Fifth National TB Epidemiological Survey;The Office of the Fifth National TB Epidemiological Survey
    Journal of Tuberculosis and Lung Health    2012, 34 (8): 485-508.  
    Abstract9932)      PDF(pc) (3293KB)(69216)       Save
    This survey aims to understand the prevalence status and trend of tuberculosis (TB) in China, and evaluate the implementation of National TB Control Programme (2001—2010). Multi-stage stratified cluster proportional random sampling method was used to select the survey population. People over 15 years old in sampled survey points were administered chest X-ray, those with suspected pulmonary TB symptoms or with suspected pulmonary TB lesion shown by X-ray were performed sputum smear and culture examination. All the bacterial strain obtained were performed drug susceptibility testing of anti-TB drugs. All active TB patients detected by this survey received the socio-economic and TB knowledge awareness questionnaire. This survey has following findings. First, the prevalence of active and smear positive was 459/100 000 and 66/100 000 respectively among population over 15 years old in 2010. Secondly, the prevalence in male was higher than in female, and gradually increase by age, peaked in 75-79 years old. Thirdly, the active and smear positive prevalence of pulmonary TB were 291/100 000 and 44/100 000 in eastern part of China, 463/100 000 and 60/100 000 in the middle part, 695/100 000 and 105/100 000 in western part, 569/100 000 and 78/100 000 in rural area, 307/100 000 and 49/100 000 in cities respectively. Fourth, the multi-drug resistance TB rate was 6.8% (19/280). Fifth, the general pulblic TB knowledge awareness rate was 57.0% (720 912/1 264 905). The sixth, the annual per capital net income of TB patient household was 3292 yuan, of those 66.8% of patients lower than 60% of nationwide per capita income. In compariton with the survey in 2000, the prevalence of smear positive pulmonary TB showed a downward trend among people over 15 years old, as well as in different age group and gender. However, the prevalence in rural area was higher than in cities, and western part also significantly higher than the middle and eastern parts. These findings indicated that although the TB prevalence has dropped, the TB burden especially for the multi-drug resistant TB is still very serious.
    Reference | Related Articles | Metrics
    Application of regression discontinuity in public health
    Yu Shengnan, Gao Qi, Zheng Liang, Shi Yuan, Chen Yijin, Li Xiujun
    Chinese Journal of Antituberculosis    2023, 45 (7): 644-650.   DOI: 10.19982/j.issn.1000-6621.20230130
    Abstract284)   HTML22)    PDF(pc) (2270KB)(666)       Save

    Regression discontinuity (RD) is a kind of statistical method for making causal inferences based on counterfactuals composed of both sides of the cutoff. In recent years, the application of RD has gradually increased in public health, especially in the fields of factors influencing air quality and the effects of related policy interventions, as well as vaccine effectiveness. Since the outbreak of the COVID-19, RD has also been increasingly applied to investigate the impact of the epidemic on public health and individual behavior. The application conditions of RD are relatively simple, and RD can reduce the effect of confounding and reflect the causal relationship between variables more realistically. In this study, based on the introduction of the idea and application of RD, the current status of its application in public health is reviewed.

    Table and Figures | Reference | Related Articles | Metrics
    Interpretation of WHO consolidated guidelines on tuberculosis, Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update
    Fu Liang, Ren Tantan, Zhang Peize, Lu Shuihua
    Chinese Journal of Antituberculosis    2023, 45 (4): 336-348.   DOI: 10.19982/j.issn.1000-6621.20220523
    Abstract909)   HTML80)    PDF(pc) (1104KB)(707)       Save

    World Health Organization (WHO) published the WHO consolidated guidelines on tuberculosis, Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update on February 15, 2022. The author introduced the main points of the updated guidelines, including the recommendations on the treatment of drug-resistant tuberculosis (focusing on a new short-term plan), management, patient care, and treatment monitoring, and discussed the feasibility of the guidelines in clinical practice and future research directions in China.

    Reference | Related Articles | Metrics
    Interpretation of WHO consolidated guidelines on tuberculosis: Module 1: prevention: tuberculosis preventive treatment
    Guo Tonglei, Xin Henan, Gao Lei
    Chinese Journal of Antituberculosis    2023, 45 (8): 723-727.   DOI: 10.19982/j.issn.1000-6621.20230199
    Abstract578)   HTML87)    PDF(pc) (1382KB)(605)       Save

    World Health Organization (WHO) published the WHO consolidated guidelines on tuberculosis: Module 1: prevention: tuberculosis preventive treatment (2020 version guideline) on February 25, 2020, and guided the implementation of the 2020 version guideline through the implementation manual which contains the details of the implementation of guidance recommendations. The 2020 version guideline integrates the latest research since the WHO released Latent tuberculosis infection: updated and consolidated guidelines for programmatic management in 2018, and updates some recommendations. The author introduces the 2020 version guideline and interprets its key recommendations, hoping to provide a reference for the implementation of tuberculosis preventive treatment in China.

    Table and Figures | Reference | Related Articles | Metrics
    Comparison of the performance of deep learning models ResNet18 and ResNet50 based on multiphase CT for the diagnosis of renal tuberculosis
    Yi Wanqing, Zheng Xueyi, Zhang Zhuang, Sun Weirong, Yuan Xiaodong
    Chinese Journal of Antituberculosis    2024, 46 (3): 288-293.   DOI: 10.19982/j.issn.1000-6621.20230375
    Abstract110)   HTML14)    PDF(pc) (1130KB)(604)       Save

    Objective: To investigate the feasibility of deep learning models based on CT images for the differential diagnosis of renal tuberculosis. Methods: A retrospective analysis was conducted on 200 patients (400 kidneys) admitted to the Eighth Medical Center of the General Hospital of the PLA from September 2018 to August 2020, diagnosed with renal tuberculosis, renal tumors, pyelonephritis, normal kidneys, renal cysts, or hydronephrosis by pathological or clinical confirmation. The 400 CT images of the kidneys were divided into the tuberculosis group (n=114) and the non-tuberculosis group (n=286), and then further divided into a training set (renal tuberculosis: 85; non-renal tuberculosis: 235) and a test set (renal tuberculosis: 29; non-renal tuberculosis: 51) with the ratio of 8∶2. Deep learning models for the unenhanced phase, corticomedullary phase, nephrographic phase, and excretory phase of the kidneys were constructed using the ResNet18 and ResNet50 networks based on the training set. The diagnostic performance of the constructed models for renal tuberculosis was evaluated based on the test set, including the calculation of the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, accuracy, and F1 score. Results: In the training set, the average age of the tuberculosis group ((41.27±11.75) years) was lower than that of the non-tuberculosis group ((54.05±13.97) years), with a statistically significant difference (t=5.753, P<0.05). In the test set, the average age of the tuberculosis group ((44.06±11.95) years) was significantly lower than that of the non-tuberculosis group ((56.12±10.73) years)(t=3.444, P<0.05). In the training set, males accounted for 66.7% (40/60) and females accounted for 33.3% (20/60) in the tuberculosis group, while in the non-tuberculosis group, males accounted for 60.9% (78/128) and females accounted for 39.1% (50/128); however, the gender distribution showed no statistically significant difference in the training set (χ2=0.009, P=0.924). In the test set, 64.3% (18/28) of individuals in the tuberculosis group were male, and 35.7% (10/28) were female; in the non-tuberculosis group, 58.7% (27/46) were male, and 41.3% (19/46) were female, with no significant difference (χ2=0.018, P=0.894). The AUC, sensitivity, specificity, accuracy, and F1 score of the four-phase images were all higher in the ResNet18 model compared to those in the ResNet50 model. The ResNet18 model demonstrated superior performance in the corticomedullary phase, with an AUC of 0.925 and corresponding sensitivity, specificity, accuracy, and F1 score of 93.1%, 86.3%, 88.7%, and 0.857, respectively. In contrast, the AUC for the medullary phase of the ResNet50 model was 0.858, with corresponding sensitivity, specificity, accuracy, and F1 score of 72.4%, 84.3%, 80.0%, and 0.724, respectively. Conclusion: The diagnostic performance of the ResNet18 model for renal tuberculosis based on multi-phase CT images was superior to that of the ResNet50 model. And the corticomedullary phase exhibited the best diagnostic performance in the ResNet18 model, indicating the high clinical application value.

    Table and Figures | Reference | Related Articles | Metrics
    Analysis of registration records of elderly pulmonary tuberculosis patients aged 65 and above in China,2015—2021
    Teng Rencong, Li Tao, LI Yuhong, Yang Chenlu, Zhang Canyou, Zhao Yanlin, Zhang Hui
    Chinese Journal of Antituberculosis    2023, 45 (4): 367-371.   DOI: 10.19982/j.issn.1000-6621.20220494
    Abstract487)   HTML35)    PDF(pc) (708KB)(627)       Save

    Objective: To analyze the registration records of elderly pulmonary tuberculosis (PTB) patients aged 65 and above in China from 2015 to 2021, to provide basis for strengthening TB control among elderly population. Methods: The medical records of elderly PTB patients aged 65 and above from January 1, 2015 to December 31, 2021 were extracted from the Tuberculosis Management Information System (TBIMS), a subsystem of the Chinese Disease Control and Prevention Information System, which included data of gender, age, ethnic, population classification, current address, case finding methods, bacteriological test result, etc. The registration number of PTB patients from 2015 to 2021 was also obtained from the TBIMS. The number of elderly populations from 2015 to 2021 was derived from the 2021 National bulletin on the development of elderly population care issued by the National Bureau of Statistics. Descriptive analysis was made on the registration data and population characteristics of elderly PTB patients aged 65 and above. Results: From 2015 to 2021, a total of 1220494 elderly PTB patients aged 65 years and above were registered in China, and the registration rate dropped from 117.8/100000 (171033/145240000) in 2015 to 81.1/100000 (162565/200560000) in 2021, showing an overall statistically significant decline trend ( χ T r e n d 2=21268.25, P<0.001). The proportion of elderly PTB patients among all PTB patients increased from 21.3% (171033/804164) in 2015 to 27.4% (162565/593743) in 2021 year by year, showing an overall statistically significant increasing trend ( χ T r e n d 2=9195.04, P<0.001). The etiologically positive rate of elderly PTB patients increased from 33.0% (56426/171033) in 2015 to 64.1% (104182/162565) in 2021 year by year, showing an statistically significant increasing trend ( χ T r e n d 2=67776.63, P<0.001). Among 1220494 elderly PTB patients, the male to female ratio was 2.37∶1 (858031/362463), the proportion of ethnic minorities was 15.7% (191525 patients), the proportion of farmers, herdsmen and fishermen was 76.8% (936988 patients), the proportions of patients from eastern, central and western regions were 28.0% (341971 patients), 36.7% (448430 patients) and 35.3% (430093 patients) respectively; the proportion of passive finding was 96.9% (1182243 patients). Conclusion: From 2015 to 2021, the registration rate of PTB patients aged 65 and above in China showed a decline trend, but its proportion among all patients had been increasing continuously. Therefore, the elderly are worth more attention, especially for men, ethnic minorities and people in the central and western regions; At the same time, scientifically and orderly developing PTB active case finding in elderly is worthy of further exploration.

    Table and Figures | Reference | Related Articles | Metrics
    Investigation and analysis of awareness rate of core knowledge of tuberculosis prevention and control of newly diagnosed pathogenic positive pulmonary tuberculosis patients
    Jiang Xiaoying, Zhang Wen, Gao Mengqiu, Zhang Zhiguo, Mi Fengling
    Chinese Journal of Antituberculosis    2023, 45 (8): 794-800.   DOI: 10.19982/j.issn.1000-6621.20230090
    Abstract220)   HTML11)    PDF(pc) (830KB)(575)       Save

    Objective: To investigate the awareness of the core knowledge of tuberculosis prevention and control among newly diagnosed pathogenic positive pulmonary tuberculosis patients. Methods: Using the prospective cohort study method, 202 newly diagnosed pathogenic positive pulmonary tuberculosis patients who met the conditions of the “home treatment management model” and were included in three municipal tuberculosis prevention and control institutions (specialized hospitals), including the Beijing Chest Hospital affiliated to Capital Medical University, the Changping District Tuberculosis Prevention and Control Institute of Beijing, and the Daxing District Center for Disease Prevention and Control of Beijing, from January 2019 to January 2023, were investigated. A self-designed survey questionnaire was used to conduct a face-to-face inquiry survey on the survey subjects at their first visit, collecting their basic information, past medical history, and current diagnosis and treatment status. The respondents who reported that they knew tuberculosis related core knowledge were further investigated the awareness of tuberculosis prevention and control core knowledge. A total of 202 questionnaires were distributed and 202 valid questionnaires were collected, with a questionnaire effectiveness rate of 100%. The general situation of the respondents and the awareness of tuberculosis prevention and control core knowledge were statistically analyzed, and the factors affecting the awareness rate were further analyzed by logistic regression. Results: Of the 202 respondents, 191 (94.55%) reported that they knew about tuberculosis, and the total awareness rate of the 8 core knowledge of tuberculosis prevention and control was 70.42% (1076/1528). Univariate analysis showed that the total awareness rate was the highest in the 15-29 year old group (76.69%, 227/296), and the lowest in the 45-59 year old group (65.20%, 193/296), with a statistically significant difference (χ2=19.236, P<0.001). The total awareness rate of non local registered residence (74.20%, 558/752), those with bachelor’s degree or above (77.02%, 191/248), those who do not drink (73.15%, 673/920) and those who used to drink but now do not (70.09%, 342/488) was significantly higher than that of registered residence (67.52%, 524/776), middle school (71.56%, 750/1048), primary school and below (60.78%, 141/232) and current drinkers (55.83%, 67/120), respectively. The differences were statistically significant (χ2 values were 8.236, 16.213, 15.589, respectively, and P values were <0.005,<0.001, and <0.001, respectively). Multivariate logistic regression analysis showed that the probability of knowing tuberculosis prevention and control core knowledge of patients with chronic diseases and patients aged 45-59 years were 30.0% (95%CI: 9.1%-98.8%) and 18.5% (95%CI: 3.5%-99.4%) of patients without chronic diseases and patients aged 15-29 years, respectively. The information channel for respondents to obtain tuberculosis prevention and control knowledge was mainly media (such as network/television/radio/leaflets), with a selection rate of 53.93% (103/191). Conclusion: The total awareness rate of tuberculosis prevention and control core knowledge of newly diagnosed pathogenic positive pulmonary tuberculosis patients was low. Targeted measures should be taken for tuberculosis patients aged 45-59, with registered residence in the city, with secondary school and primary school education and below, and drinking now, and health education for tuberculosis prevention and control should be carried out through various information channels.

    Table and Figures | Reference | Related Articles | Metrics
    Research progress on the correlation between intestinal microbiota short chain fatty acids and pulmonary tuberculosis
    Zhang Xiaomeng, Li Min, Chai Yinghui, Zhou Jing, Lei Hong
    Chinese Journal of Antituberculosis    2023, 45 (7): 699-706.   DOI: 10.19982/j.issn.1000-6621.20230079
    Abstract274)   HTML11)    PDF(pc) (898KB)(554)       Save

    Short chain fatty acids (SCFA) are the main metabolites of the gut microbiota, mainly including formic acid, acetic acid, propionic acid, butyric acid and their branched chain fatty acids, and some salts. Research has shown that there is a significant direct correlation between SCFA and the occurrence and development of pulmonary tuberculosis. Pulmonary tuberculosis leads to imbalance of gut microbiota, thereby reducing the abundance of SCFA, which affects the host immune system and the response of inflammatory factors; the disorder of host immune system and inflammatory factor will promote the occurrence and development of pulmonary tuberculosis.The author reviewed the correlation between SCFA and pulmonary tuberculosis, the possible regulatory mechanism between them, and whether it was possible to improve the abundance of SCFA in the body by regulating intestinal flora to achieve the purpose of treatment or adjuvant treatment of pulmonary tuberculosis.

    Table and Figures | Reference | Related Articles | Metrics
    Journal of Tuberculosis and Lung Health    2019, 41 (10): 1025-1073.   DOI: 10.3969/j.issn.1000-6621.2019.10.001
    Abstract3152)   HTML482)    PDF(pc) (2241KB)(3128)       Save
    Table and Figures | Reference | Related Articles | Metrics
    Study on the early efficacy and safety of the regimen containing bedaquiline in the treatment of multidrug-resistant pulmonary tuberculosis
    DING Cai-hong, XIONG Yu, WANG Qing, GAO Xu-sheng, HAO Yan
    Chinese Journal of Antituberculosis    2021, 43 (9): 893-898.   DOI: 10.3969/j.issn.1000-6621.2021.09.007
    Abstract662)   HTML23)    PDF(pc) (780KB)(626)       Save

    Objective To investigate the early efficacy and safety of the regimen containing bedaquiline in the treatment of multidrug-resistant pulmonary tuberculosis (MDR-PTB). Methods According to the inclusion criteria, 79 MDR-PTB patients diagnosed in Shandong chest hospital from September 2018 to December 2020 were prospectively studied, all of them completed 24-week anti-tuberculosis treatment containing bedaquiline. Basic characteristics (gender, age, residence, body mass index (BMI)) and clinical information (mycobacterium sputum smear and culture results, electrocardiogram, blood routine, liver and kidney function, chest CT, adverse drug reactions), etc.) were collected. To monitor the time of negative conversion of sputum culture, the occurrence of adverse drug reactions, and the treatment outcome during the treatment containing bedaquiline were monitored, and the factors affecting the treatment outcome were analyzed. Results Of the 79 cases, 72 (91.1%) had good outcomes and 7 (8.9%) had adverse outcomes after completing 24-week treatment. Multivariate logistic regression analysis showed that BMI <18.5 (20.8% (5/24)) and aged ≥45 years (27.8% (5/18)) were the risk factors for adverse outcomes (OR (95%CI) were 9.393 (1.443-61.125) and 7.769 (1.289-46.835), respectively. The median (quartile) of sputum culture negative conversion time was 4 (2, 8) weeks. The cumulative sputum culture negative conversion rate gradually increased with the extension of treatment time. The sputum culture negative conversion rates at 2, 4, 8, 12, 16, 20 and 24 weeks were 30.4% (24/79), 51.9% (41/79), 70.9% (56/79), 83.5% (66/79), 87.3% (69/79), 88.6% (70/79) and 91.1% (72/79), respectively. Fifty-three patients (67.1%) had adverse drug-resistant, of which one had serious gastrointestinal reactions, 30 (38.0%) had prolonged Q-Tc interval, and Q-Tc interval ≥500 ms was found in 15 (19.0%); the Q-Tc interval increased first and then decreased with the increase in usage time of bedaquiline, and the peak was at the 12th week ((436.10±27.97) ms). Conclusion The treatment containing bedaquiline showed good outcome for MDR-PTB, with a higher rate of negative conversion of sputum culture in the early stage; adverse outcomes were more likely to happen in malnutrition, middle-aged and elderly patients. The Q-Tc interval of patients during treatment should be monitored.

    Table and Figures | Reference | Related Articles | Metrics
    Strive for excellence with an emphasis on fundamentals and innovations: interpretation of the WHO Global Tuberculosis Report 2022
    Shu Wei, Liu Yuhong
    Chinese Journal of Antituberculosis    2023, 45 (5): 454-457.   DOI: 10.19982/j.issn.1000-6621.20230102
    Abstract754)   HTML82)    PDF(pc) (1025KB)(545)       Save

    Tuberculosis (TB) prevention and control work needs innovative research and development to accelerate the implementation of the World Health Organization (WHO) End TB Strategy. On 27th October 2022, WHO released the Global Tuberculosis Report 2022, updating the latest progress of global TB research and innovation. This paper reviews the key achievements in the areas of research and innovation for new diagnostics, drugs and regimens as well as vaccines introduced in the report, and discusses some of China’s indigenous progresses in related areas. This paper aims to make China’s TB professionals better informed about the latest research development in TB prevention and control around the globe, fostering indigenous TB innovation efforts with greater originality.

    Reference | Related Articles | Metrics
    Progress and reflections on development of laboratory diagnostic technology for tuberculosis
    Li Shanshan, Wang Yufeng, Shu Wei, Pang Yu
    Chinese Journal of Antituberculosis    2023, 45 (5): 446-453.   DOI: 10.19982/j.issn.1000-6621.20220535
    Abstract585)   HTML67)    PDF(pc) (1721KB)(562)       Save

    Rapid and accurate laboratory diagnostic techniques are of great importance for the prevention and control of tuberculosis (TB). Since the discovery of Mycobacterium tuberculosis by Robert Koch in 1882, significant achievements have been made in the development of TB diagnosis from traditional etiological diagnostics to immunological and molecular diagnostics. Nevertheless, the current diagnostic technologies remain unable to meet current requirements, thereby hampering the achievement of the End TB Strategy by 2035. In view of these challenges, the authors discuss the core diagnostic needs of TB prevention and control, and explore the important development pipeline of future laboratory diagnosis.

    Table and Figures | Reference | Related Articles | Metrics
    Updates on the application of whole-genome sequencing for within-host heterogeneity of Mycobacterium tuberculosis
    Zhang Rui, Liu Yanping, Qian Jun, Fang Qianglin, Yang Chongguang
    Chinese Journal of Antituberculosis    2022, 44 (11): 1199-1204.   DOI: 10.19982/j.issn.1000-6621.20220250
    Abstract444)   HTML25)    PDF(pc) (1201KB)(594)       Save

    Tuberculosis (TB) is an infectious disease caused by the Mycobacterium tuberculosis (MTB). The genetic polymorphism of the MTB complex is relatively conservative. With the impressive progress in the field of next generation sequencing (NGS) and the whole-genome sequencing (WGS) analysis, vast genetic heterogeneity has been observed in MTB isolates from different hosts and even within the same host. The reasons for this phenomenon are complex, at least including multiple or mixed infections of different strains and microevolution of the same strain within the host. Still, its mechanism and role in drug resistance, transmission, diagnosis and treatment of TB are not fully understood. This article reviews the identification and current research progress of the within-host genetic heterogeneity of MTB.

    Table and Figures | Reference | Related Articles | Metrics
    Expert consensus on a standard of activity judgment of pulmonary tuberculosis and its clinical implementation
    Clinical Research Center for Infectious Disease, the Third People’s Hospital of Shenzhen, Editorial Board of Chinese Journal of Antituberculosis National
    Journal of Tuberculosis and Lung Health    2020, 42 (4): 301-307.   DOI: 10.3969/j.issn.1000-6621.2020.04.001